BioSpace News Archive

Bicycle Therapeutics plc today announced that management will participate in the following investor conferences in March.

Can-Fite BioPharma Ltd today announced it received a Notice of Allowance from the Canadian Intellectual Property Office for its patent application titled “An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation”.

Covalon Technologies Ltd. today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.

Form Bio and Ginkgo Bioworks today announced a new partnership to provide a complete and holistic solution offering for AAV gene therapy design and development.

Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 44th Annual Healthcare Conference, on Wednesday March 6th at 1:30 pm ET.

bit.bio, the company coding human cells for novel cures, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced bit.bio as an inaugural partner of the Ginkgo Technology Network.

XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following March 2024 investor conferences.

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced the launch of the Riskguard™ hereditary cancer test in the United States.

Integra LifeSciences Holdings Corporation reported financial results for the fourth quarter and full year ended December 31, 2023.

Centogene N.V. announced that the Company received a staff determination letter on Feb. 27, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company of the determination of the Nasdaq staff to delist the Company’s securities from The Nasdaq Global Market due to non-compliance with the minimum USD $15 million Market Value of Publicly Held Shares requirement as set forth in Nasdaq Listing Rule 5450.